Literature DB >> 29274322

Subpopulations of cancer stem cells found in papillary thyroid carcinoma.

Saied Mirshahidi1, Alfred Simental2, Steve C Lee2, Pedro A De Andrade Filho2, Nathaniel R Peterson2, Wenlong Cao2, Rosalia de Necochea-Campion3, Hao Yang4, Penelope Duerksen-Hughes5, Xiangpeng Yuan6.   

Abstract

Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer and while it has a generally good prognosis, tumor recurrence remains a major clinical challenge. Studying laboratory cell lines as well as clinical specimens indicate that PTC may follow the cancer stem cell (CSC) model. However, CSC characteristics relevant in PTC initiation and progression remain largely unknown. Here we studied a population of sphere-growing tumor cells isolated from primary cultures of clinical PTC. These sphere-growing cells consisted of aldehyde dehydrogenase positive (ALDH+) and ALDH negative (ALDH-) cell subpopulations and demonstrated a hierarchical pattern of cell division. Using combinations of selective depletion, specific inhibition and cell sorting, we found that both subpopulations of the sphere cells were able to self-renew and initiate xenograft tumors independently, and fulfilled the definition of CSC. Importantly, when the subpopulations functioned together, the cancer-initiation efficiency and the xenograft tumor progression were significantly enhanced compared to either subpopulation alone. These data revealed crucial roles of ALDH- CSC in PTC biology and suggested that CSC subpopulations function cooperatively to control PTC initiation and progression. Together, our study indicates that CSC subpopulations isolated from clinical specimens offer unprecedented opportunities for investigating PTC pathogenesis and developing effective therapies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aldehyde dehydrogenase; Cancer stem cells; Patient-derived xenograft tumor; Primary cells; Subpopulations of cancer stem cells; Thyroid carcinoma

Mesh:

Substances:

Year:  2017        PMID: 29274322     DOI: 10.1016/j.yexcr.2017.12.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

Review 1.  Functions of stem cells of thyroid glands in health and disease.

Authors:  Ebtesam A Al-Suhaimi; Khulood Al-Khater
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 2.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

Review 3.  Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis.

Authors:  Laura Sofia Carvalho; Nélio Gonçalves; Nuno André Fonseca; João Nuno Moreira
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

Review 4.  Stem Cell Therapy for Thyroid Diseases: Progress and Challenges.

Authors:  Sunyi Ye; Zhu Lixian Zhu
Journal:  Curr Ther Res Clin Exp       Date:  2022-03-05

5.  Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells.

Authors:  Jie Liu; Hu Cai; Heqing Yi; Xin Li; Yunsong Peng; Linfa Li
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.